Germany vs Mali: The number of people with susceptibility test result for rifampicin
Germany
1,440
in 2021
Mali
1,234
in 2021
Germany rank
58th
Mali rank
61st
The number of people with susceptibility test result for rifampicin over time
- Germany
- Mali
How they compare
Germany currently reports 1,440 against 1,234 in Mali, a difference of 206.
That makes Germany's figure about 1.2 times Mali's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Mali ahead.
Germany ranks 58th and Mali ranks 61st of 155 countries.
Across the 2 decades both report, Germany averaged higher in 1 and Mali in 1.
Head to head by decade
| Decade | Germany | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,298 | 141 | 1,157 | Germany |
| 2020s | 1,502 | 1,823 | 320.5 | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Germany or Mali?
- Germany, at 1,440 against 1,234 in Mali as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Germany and Mali?
- 206, with Germany ahead.
- How many years of comparable data are there for Germany and Mali?
- 5 years are reported by both, from 2017 to 2021.
- How do Germany and Mali rank globally for the number of people with susceptibility test result for rifampicin?
- Germany ranks 58th and Mali ranks 61st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.